Rare sugar l-sorbose exerts antitumor activity by impairing glucose metabolism

Hui-Lin Xu,Xiaoman Zhou,Shuai Chen,Si Xu,Zijie Li,Hideki Nakanishi,Xiao-Dong Gao

DOI: https://doi.org/10.1038/s42003-023-04638-z

IF: 6.548

2023-03-12

Communications Biology

Abstract:Rare sugars are monosaccharides with low natural abundance. They are structural isomers of dietary sugars, but hardly be metabolized. Here, we report that rare sugar l -sorbose induces apoptosis in various cancer cells. As a C-3 epimer of d -fructose, l -sorbose is internalized via the transporter GLUT5 and phosphorylated by ketohexokinase (KHK) to produce l -sorbose-1-phosphate (S-1-P). Cellular S-1-P inactivates the glycolytic enzyme hexokinase resulting in attenuated glycolysis. Consequently, mitochondrial function is impaired and reactive oxygen species are produced. Moreover, l -sorbose downregulates the transcription of KHK-A, a splicing variant of KHK. Since KHK-A is a positive inducer of antioxidation genes, the antioxidant defense mechanism in cancer cells can be attenuated by l -sorbose-treatment. Thus, l -sorbose performs multiple anticancer activities to induce cell apoptosis. In mouse xenograft models, l -sorbose enhances the effect of tumor chemotherapy in combination with other anticancer drugs. These results demonstrate l -sorbose as an attractive therapeutic reagent for cancer treatment.

biology